Levosimendan is a pharmaceutical compound with nitrile, pyridazinone, and hydrazone structural features. It is primarily recognized as a vasodilator agent and a cardiotonic drug, and it also functions as a phosphodiesterase inhibitor.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 141505-33-1
Odalasvir
pharmaceutical raw material
Cagrilintide/semaglutide
pharmaceutical raw material
Enavogliflozin
pharmaceutical raw material
TL-895
pharmaceutical raw material
6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
pharmaceutical intermediate
2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile
WHXMKTBCFHIYNQ-SECBINFHSA-N
C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N